254 related articles for article (PubMed ID: 1476671)
1. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y
Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671
[TBL] [Abstract][Full Text] [Related]
2. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
Xiang J; Moyana T; Liu E
Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
[TBL] [Abstract][Full Text] [Related]
3. Genetic engineering of anticolorectal carcinoma Fv molecule in myeloma cells.
Xiang J
Mol Biother; 1992 Jun; 4(2):70-6. PubMed ID: 1515097
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of functional cDNA genes of a mouse/human chimeric antibody rcM4.
Boyd M; Xiang J
Tumori; 1994 Dec; 80(6):473-9. PubMed ID: 7900239
[TBL] [Abstract][Full Text] [Related]
5. Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.
Xiang J; Chen Z
Immunology; 1992 Feb; 75(2):209-16. PubMed ID: 1551684
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
7. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
8. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
9. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
10. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
11. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
12. Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.
Liu HL; Parkes DL; Langton BC; Xuan JA; Longhi M; Elliger SS; Chao LA; McGrogan MP; Brandis JW; Shawver LK
Biochem Biophys Res Commun; 1995 Jun; 211(3):792-803. PubMed ID: 7598708
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of phage-displayed single chain variable fragments of monoclonal antibody MC5 recognizing colorectal carcinoma].
He FT; Li RF; Zhang Y; Ji Q; Chen BJ; Qiao TD; Fan DM
Ai Zheng; 2002 Jun; 21(6):636-9. PubMed ID: 12452065
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
15. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
16. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
17. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
Zhang M; Yu L; Huang H
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
[TBL] [Abstract][Full Text] [Related]
18. Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.
Xiang J; Koropatnick J; Qi Y; Luo X; Moyana T; Li K; Chen Y
Immunology; 1993 Apr; 78(4):574-81. PubMed ID: 8495976
[TBL] [Abstract][Full Text] [Related]
19. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
[TBL] [Abstract][Full Text] [Related]
20. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
